Treatment with metformin is associated with a prolonged survival in patients with hepatocellular carcinoma - Concepedia

Concepedia

Publication | Closed Access

Treatment with metformin is associated with a prolonged survival in patients with hepatocellular carcinoma

65

Citations

29

References

2019

Year

Lena Schulte, Bernhard Scheiner, Torsten Voigtländer, Sandra Koch, Nóra Schweitzer, Silke Marhenke, Philipp Ivanyi, Michael P. Manns, Thomas Rodt, Jan B. Hinrichs,

Liver International

Abstract

Treatment with metformin was associated with an improved survival in patients with T2DM and HCC. This effect was most pronounced in patients at potentially curative tumour stages.

References

	Year	Citations

Page 1